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Summary
The therapeutic efficacy of single intramuscular doses of
ceftriaxone (Rocephin; Roche) (62,S, 125 and 250 mg), admini-
stered without probenecid, was evaluated in 167 adult males
with uncomplicated acute gonococcal urethritis. Cure rates
of 100% were achieved at 62,5 mg and 250 mg. In the 125 mg
dose group, Neisseria gonorrhoeae was isolated from 1 patient
at follow-up after therapy. Reinfection was suspected, since
this patient returned on day 10 and admitted to sexual contact
2 days previously. Side-effects were minimal, and patient
acceptance was better for ceftriaxone dissolved in lignocaine
than in sterile water. Chlamydia trachomatis was detected at
follow-up in 14,4% patients, confirming that ceftriaxone has
no significant effect on chlamydial infection and additional
treatment is necessary for patients with coexistent infection.
S AIr Med J 1990; 78: 187-189.
Ceftriaxone (Rocephin; Roche), an extended spectrum cephalo-
sporin with long plasma half-life, has been shown to give
excellent cure rates for uncomplicated gonorrhoea, irrespective
of the penicillin susceptibility of Neisseria gonorrhoeae strains.1-'
Cure rates of 100% have been achieved with single intra-
muscular doses ranging from 125 mg to 500 mg. In a dose-
response study, Rajan et al. 8 showed the efficacy of single
doses as low as 32,5 mg, 62,5 mg and 125 mg, each accom-
panied by oral probenecid for the treatment of gonococcal
urethritis (GU). Furthermore, in a pilot study using small
numbers of patients, Eichmann et al. 2 achieved good results at
a single low dose of 50 mg administered without probenecid.
In South Africa, the Medicines Control Council has licensed
ceftriaxone, but only the 250 mg single intramuscular dose has
approval for the therapy of gonorrhoea. With the increasing
prevalence of penicillinase-producing strains of N. gonorrhoeae
(PPNG) in patients attending the sexually transmitted diseases
clinic at this hospital, the need to change to an antimicrobial
agent active against both penicillin-sensitive and -resistant
strains has become essential. Locally obtained proof of the
efficacy of ceftriaxone would make it cost-effective as a poten-
tial first-choice agent for the treatment of GU.
Against this background and with the knowledge that pro-
benecid does not affect the renal excretion of ceftriaxone,9
a study was undertaken to assess the efficacy of various single
low doses of ceftriaxone in the treatment of uncomplicated
gonorrhoea.
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Patients and methods
Adult males presenting to the Sexually Transmitted Diseases
(STD) Clinic at King Edward VIII Hospital, Durban, with a
complaint of urethral discharge were considered for the study.
Informed consent was obtained from all patients and the study
was approved by the Ethics Committee of the Faculty of
Medicine, University of Natal, and also by the Medicines
Control Council of South Africa.
At the initial visit, endo-urethral swab specimens were
collected from each patient for the preparation of a smear for
Gram staining and for isolation of N. gonorrhoeae. Patients
with smears in which characteristic Gram-negative intracellular
diplococci were seen were included in the study and assigned
randomly to receive a single intramuscular dose of 62,5 mg,
125 mg or 250 mg ceftriaxone.
All patients were asked to refrain from sexual intercourse
and return after 3 days. At the follow-up visit, repeat endo-
'urethral swab specimens were collected for a smear for Gram
staining and culture for N. gonorrhoeae. If 4 or more poly-
morphonuclear neutrophils per high-power field were seen in
the Gram stain, further endo-urethral specimens were obtained
for the detection of Chlamydia trachomatis and Ureaplasma
urealyricum. These patients were then also given a course of
oral minocycline (lOO mg twice a day for 14 days).
Microbiological investigations
Endo-urethral specimens were obtained by inserting calcium
alginate-tipped swabs 2-3 cm beyond the meatus and gently
rotating them. Smears for Gram staining were prepared, stained
and read at the clinic, while those for direct immunofluo-
rescence staining (Microtrak; Syva Corp.) for C. rrachomaris
were fixed with acetone and processed according to manufac-
turer's instructions.
Specimens for the isolation of N. gonorrhoeae and U. urealy-
ticum were inoculated onto modified New York City Medium
and U9 broth respectively. All inoculated media were imme-
diately placed in candle extinction jars and transported to the
laboratory within 30 minutes. N. gonorrhoeae and U. urealy-
cicum were identified by standard laboratory methods, as
described previously.1O
Results
The study period extended from 14 June 1988 to 12 July 1988
during which time a total of 197 adult males were enrolled. Of
these, 167 patients returned for follow-up (within 3 - 7 days of
receiving treatment) and could be assessed. The average age of
the patients was 27 years (range 18 - 57 years).
For the first 50 patients in the study, ceftriaxone was
administered dissolved in sterile water, and 24 of these men
(48%) complained of moderate-to-severe pain at the site of
injection. For the remaining 117 patients, ceftriaxone was
administered dissolved in 1% lignocaine. Of these men, only
10 (8,6%) complained of minimal pain at the site of injection.
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* 1 patient in whom reinfection was suspected.
Discussion
TABLE 11. RESULTS OF MICROBIOLOGICAL
INVESTIGATIONS PERFORMED AT FOLLOW-UP VISIT
No. %
At the follow-up visit, 18 patients complained of burning on
micturition; endo-urethral smears of these patients showed ~
4 polymorphonuclear neutrophils in 13, and in 10 C. lracho-
malis was detected.
In vilro susceptibility tests on local isolates of N. gonorrhoeae
from PlJtients attending the same sexually transmitted diseases
clinic itt which this study was undertaken, have shown a uni-
form sensitivity to ceftriaxone. The 90% minimum inhibitory
concentration of these isolates is as low as ~ 0,007 ,ug/ml. l1
This probably explains the effectiveness of the low dose
ceftriaxone (62,5 mg) administered without probenecid in this
study.
All patients treated, including 26 (15,6%) from whom PPNG
strains were isolated, were cured with the three dosage regimen
used. The exception was a patient in whom reinfection was
suspected. This patient returned on day 10 after therapy and
admitted to sexual contact 2 days previously.
The use of sterile water as a diluent resulted in a significant
number of patients (24 of 50) complaining of moderate-to-
severe pain at the site of injection. When the preparation was
reconstituted in lignocaine this complaint was no longer volun-
teered and on enquiry only 8,6% patients stated that they
experienced minimal pain at the site of injection. Side-effects
were minimal, with 4 and 6 patients complaining of nauseous-
ness and a feeling of dizziness respectively. Full blood counts,
liver and renal function tests were not performed in this study,
but in studies in which these tests have been undertaken, no
harmful effects were noted.4•6•12
Although investigations for C. lrachomalis were not included
among the initial investigations performed before ceftriaxone
therapy, the fmding of C. lrachomacis in 14,9% of patients at
the follow-up visit is similar to prevalences of 17% and 10,7%
found in two inde~endent studies on male urethritis at the
same STD clinic. IO, 3This is in agreement with the fmdings of
other workers1,4 that chlamydial infections are not cured by
single-dose regimens of ceftriaxone. Patients with coexisting
C. trachomatls infection ought to be adequately treated after
ceftriaxone by a 7-day course of tetracycline.!3
With the local prevalence of PPNG strains having risen
steadily from the 5% reported in 198315 to 26%.in 1986,10 we
have recommended that penicillin no longer be used for the
therapy of gonococcal urethritis, and a suitable alternative be
employed. 14 This study shows that ceftriaxone would be an
ideal alternative because of its excellent -activity against both
penicillin-sensitive and -resistant strains of N. gonorrhoeae.
Furthermore, at a dose of 125 mg, it has been projected to cost
closer to the currently used regimen of 4,8 million units of
procaine penicillin with oral probenecid and much less th~
other single-dose treatment regimens.4 It should be noted that
since the completion of this study, ceftriaxone at a single
intramuscular dose of 125 mg has been made available at the
STD clinic at this hospital for first-line therapy for gonococcal
urethritis.
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C. trachomatis + U. urealyticum
No agent detected
Only 4 patients complained of feeling nauseous and 6 of
feeling slightly dizzy at the time of injection. No other adverse
reactions were recorded.
The results of treatment with the different intramuscular
doses of ceftriaxone are shown in Table I. Characteristic
intracellular diplococci were seen in only 1 Gram-stained
smear, and culture yielded N. gonorrhoeae; the patient from
whom these smears were taken returned on day 10 and
admitted to sexual contact 2 d.ays previously. PPNG strains
were detected in 26 patients (15,6%).
Results of microbiological investigation of endo-urethral
specimens collected at the follow-up visit are shown in Table
n. In a total of 49 patients (29,3%) ~ 4 polymorphonuclear
neutrophils per high-power field were seen. C. lrachomacis was
detected in 25 (14,9%) and U. urealylicum alone in 8 patients
(4,8%).
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mycin for trearmenr of uncomplicated gonorrhoea in men. Lancec 1983; 2:
67-70.
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Summary
Seventy-five men presenting with persistent urethral discharge
after penicillin therapy were investigated for sexually trans-
mitted pathogens during July - September 1987. The major
aetiological agent isolated was Neisseria gonorrhoeae (58
patients (77,3%». Penicillinase-producing N. gonorrhoeae
(PPNG) accounted for 58,6% of 58 isolates. Chlamydia tracho-
matis was detected in 10,7% of patients and Trichomonas
vaginalis in 14,7% of patients. When there is a high prevalence
of PPNG, the use of penicillin as a first-line agent for therapy
should be discontinued in favour of an agent active against
PPNG and non-PPNG strains. Furthermore, in view of the
relatively high prevalence of T. vaginalis, patients returning
with persistent urethral discharge should be investigated and
treated for infection with this protozoan.
S AIr Med J 1990; 78: 189-191.
Neisseria gonorrhoeae has been shown to be the most common
cause of acute urethritis in untreated black men in South
Africa, 1-) with studies from several centres revealing pre-
valences in excess of 90%.4.5
In Durban, the prevalence of penicillinase-producing strains
of N. gonorrhoeae (PPNG), which were first detected in 1977,6
has increased steadily to reach 26,2% in December 1985.5
Despite the high prevalence of PPNG, at the time of this
study the standard antibiotic therapy employed locally (at' the
Sexually Transmitted Diseases Clinic) for patients presenting
with untreated acute gonococcal urethritis (diagnosed at the
clinic by Gram staining) was intramuscular procaine penicillin
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in a dose of 4,8 million units plus oral probenicid 1 g. For
penicillin-allergic patients, oral minocycline (lOO mg twice a
day for 7 days) was given as alternative therapy.
Patients treated with the above regimen occasionally return
to the clinic complaining of persistent urethral discharge.
Because of the high local prevalence of PP G and the relatively
low prevalence of associated chlamydial infection - 12%
reported from Johannesburg7 and 17% reported 10cally5 - it
has been assumed that most persistent infections are due to
PPNG and such patients are usually treated with intramuscula;
spectinomycin or oral tetracycline, depending on the findings
obtained from Gram-stained endo-urethral smears.
Since no systematic study had previously been performed to
ascertain the aetiology of urethritis in such patients, a study
was therefore undertaken to determine the aetiology of ure-
thritis in patients who, having received procaine penicillin plus
probenicid therapy for gonococcal urethritis, returned with
persistent urethral discharge.
Patients and methods
A total of 75 black men were investigated during the period
July - September 1987. All patients had returned -to the
Sexually Transmitted Diseases (STD) Clinic at King Edward
VIII Hospital complaining of persistent urethral discharge
after having been given the standard treatment. On specific
questioning, all patients denied having had any sexual contact
subsequent to treatment. Informed consent was obtained before
collection of specimens.
Endo-urethral specimens were obtained from each patient
using sterile calcium alginate-tipped swabs. These swabs were
processed as follows: (i) a smear for Gram staining; (iz) a wet-
mount; and (iiz) a smear for direct immunofluorescence staining
for Chlamydia trachomatis (Microtrak; Syva).
Gram-stained urethral smears were examined microscopically
for the presence of inflammatory cells and bacteria. Urethritis
was regarded as being present if more than 4 inflammatory
cells per high-power oil-immersion field (X 1000) were
